Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 3, 2004, Pages 401-407

  Walcourt, Asikiya ^a   Loyevsky, Mark ^a   Lovejoy, David B ^b   Gordeuk, Victor R ^a   Richardson, Des R ^b  

^a HOWARD UNIVERSITY   (United States)

^b CHILDREN S CANCER INSTITUTE AUSTRALIA FOR MEDICAL RESEARCH   (Australia)

Author keywords

Chelators; Lipophilic; Neoplastic cells

Indexed keywords

2 HYDROXY 1 NAPHTHYLALDEHYDE 4 PHENYL 3 THIOSEMICARBAZONE; 2 HYDROXY 1 NAPHTHYLALDEHYDE ISONICOTINOYLHYDRAZONE; ANTIMALARIAL AGENT; CHLOROQUINE; DEFEROXAMINE; HYDRAZONE DERIVATIVE; IRON CHELATING AGENT; THIOSEMICARBAZONE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SENSITIVITY; GROWTH INHIBITION; IN VITRO STUDY; IRON CHELATION; NONHUMAN; PLASMODIUM FALCIPARUM;

ANIMALIA; PLASMODIUM FALCIPARUM;

EID: 0348110320     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(03)00248-6     Document Type: Article

References (16)

1. Becker E., Lovejoy D.B., Green J.M., Watts R., Richardson D.R. Novel aroylhydrazone iron chelators differ in their iron chelation efficacy and anti-proliferative activity: identification of a new class of potential anti-proliferative agents. Br. J. Pharmacol. 138:2003;819-830.
2. Cabantchik Z.I., Moody-Haupt S., Gordeuk V.R. Iron chelators as anti-infectives; malaria as a paradigm. FEMS Immunol. Med. Microbiol. 26:1999;289-298.
3. Chaston T., Lovejoy D., Watts R.N., Richardson D.R. Examination of the anti-proliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared to desferrioxamine and the potent PIH analogue 311. Clin. Cancer Res. 9:2003;402-414.
4. Clarke C.J., Eaton J.W. Hydrophobic iron chelators as new anti-malarial drugs. Clin. Res. 38:1990;300A.
5. Gordeuk V.R., Thuma P.E., Brittenham G.M., Zulu S., Simwanza G., Mhangu A., Flesch G., Parry D. Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia. Blood. 79:1992;308-312.
6. Gordeuk V.R., Thuma P.E., McLaren C.E., Biemba G., Zulu S., Poltera A.A., Askin J.E., Brittenham G.M. Transferrin saturation and recovery from coma in cerebral malaria. Blood. 85:1995;3297-3301.
7. Hershko C., Peto T.E.A. Desferoxamine inhibition of malaria is independent of host iron status. J. Exp. Med. 168:1988;375-387.
8. Lovejoy D.B., Richardson D.R. Novel "hybrid" iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective anti-proliferative activity against tumor cells. Blood. 100:2002;666-676.
9. Marsh K., Snow R.W. 30 years of science and technology: the example of malaria. Lancet. 349(Suppl. III):1997;1-2.
10. Richardson D.R. Therapeutic potential of iron chelators. Exp. Opin. Invest. Drugs. 8:1999;2141-2158.
11. Richardson D.R., Ponka P. Orally effective iron chelators for the treatment of iron overload disease: the case for a further look at pyridoxal isonicotinoyl hydrazone (PIH) and its analogs. J. Lab. Clin. Med. 132:1998;351-352.
12. Richardson D.R., Tran E.H., Ponka P. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective anti-proliferative agents. Blood. 86:1995;4295-4306.
13. Rubin H., Salem J.S., Li L.S., Yang F.D., Mama S., Wang Z.M., Fisher A., Hamann C.S., Cooperman B.S. Cloning, sequence determination and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum: a target for anti-malarial therapy. Proc. Natl. Acad. Sci. U.S.A. 90:1993;9280-9284.
14. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science. 193:1976;673-675.
15. Tsafack A., Golenser J., Libman J., Shanzer A., Cabantchik Z.I. Mode of action of iron(III) chelators as anti-malarials. 3. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum. Mol. Pharmacol. 47:1995;403-409.
16. Tsafack A., Loyevsky M., Ponka P., Cabantchik Z.I. Mode of action of iron(III) chelators as anti-malarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives. J. Lab. Clin. Med. 127:1996;574-582.